Paula Littlejohn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Paula Littlejohn has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Bb Finlay
Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada
5 shared publications - Erin Brown
Kwantlen Polytechnic University Department of Biology Health Science Program Surrey, BC Canada
3 shared publications - Irene Cop
Kwantlen Polytechnic University Department of Biology Health Science Program Surrey, BC Canada
3 shared publications - Karen M. Davison
Kwantlen Polytechnic University
3 shared publications - Rimi Afroze
Kwantlen Polytechnic University Department of Biology Health Science Program Surrey, BC Canada
3 shared publications - Avril Metcalfe-Roach
Department of Microbiology and Immunology, University of British Columbia
2 shared publications
Latest Publications
- 27 August 2026
- Published by Springer Nature in Nature Reviews Microbiology
- p. 1-16
The gut microbiota in malnutrition
- 27 August 2026
- Published by Springer Nature in Nature Reviews Microbiology
- p. 1-16
The gut microbiota in malnutrition
- Open Access
- 14 November 2024
- Published by BMJ in BMJ Nutrition, Prevention & Health
- Vol. 7 (2) , 217-220
Nutritional deficiencies and associated pathologies present unique challenges of diagnosing paediatric inflammatory bowel disease in sub-Saharan Africa
Inflammatory bowel disease (IBD) represents two idiopathic conditions (Crohn’s and ulcerative colitis (UC)) of chronic inflammation of the gastrointestinal tract affecting all ages with no known cure. Approximately 4.9 million cases of IBD were reported in 2019, and this number is projected to increase. 1 IBD is driven by intestinal epithelial damage and dysfunction, dysbiotic gut microbiome and inappropriate immune response in genetically susceptible individuals. Clinical presentations are abdominal pain, diarrhoea, rectal bleeding, malnutrition and poor growth in children and adolescents.2 Diagnosis involves taking a comprehensive history, conducting relevant investigations, performing endoscopy and biopsy on patients with relevant clinical features by a well-trained clinician. Specific tissue histological findings such as neutrophilic inflammation, cryptitis and crypt abscess for UC and non-caseating granuloma in Crohn’s disease (CD) and radiological imaging are used to confirm the diagnosis.3 A delay in diagnosis or misdiagnosis resulting in untreated IBD can lead to worsened clinical outcomes. This includes persistent inflammation, development of systemic symptoms, potential complications like stenosis and fistulas with increased risk of bowel surgery.4 5 Compounding this problem are nutritional deficiencies, a frequent complication and comorbidity of IBD. Overt malnutrition (ie, undernutrition and overnutrition) like IBD is characterised by chronic inflammation, mucosal damage, intestinal barrier dysfunction, gut microbiome dysbiosis, altered immune response and malabsorption.6 In countries where childhood undernutrition is endemic, this presents an additional challenge in distinguishing malnutrition secondary to IBD. Additionally, nutritional deficiencies can worsen IBD pathophysiology and impede therapeutic response complicating disease management.6 This may lead to further misdiagnosis and underreporting of IBD’s prevalence in sub-Saharan Africa. Therefore, there is a crucial need to understand these challenges and underlying malnutrition in these settings. Moreover, reconciling malnutrition-driven pathologies may reveal unique subtypes of IBD, requiring a different approach to diagnosis and management.
- 14 November 2024
- Published by BMJ in BMJ Nutrition, Prevention & Health
- Vol. 7 (2) , 217-220
Open AccessNutritional deficiencies and associated pathologies present unique challenges of diagnosing paediatric inflammatory bowel disease in sub-Saharan Africa
Inflammatory bowel disease (IBD) represents two idiopathic conditions (Crohn’s and ulcerative colitis (UC)) of chronic inflammation of the gastrointestinal tract affecting all ages with no known cure. Approximately 4.9 million cases of IBD were reported in 2019, and this number is projected to increase. 1 IBD is driven by intestinal epithelial damage and dysfunction, dysbiotic gut microbiome and inappropriate immune response in genetically susceptible individuals. Clinical presentations are abdominal pain, diarrhoea, rectal bleeding, malnutrition and poor growth in children and adolescents.2 Diagnosis involves taking a comprehensive history, conducting relevant investigations, performing endoscopy and biopsy on patients with relevant clinical features by a well-trained clinician. Specific tissue histological findings such as neutrophilic inflammation, cryptitis and crypt abscess for UC and non-caseating granuloma in Crohn’s disease (CD) and radiological imaging are used to confirm the diagnosis.3 A delay in diagnosis or misdiagnosis resulting in untreated IBD can lead to worsened clinical outcomes. This includes persistent inflammation, development of systemic symptoms, potential complications like stenosis and fistulas with increased risk of bowel surgery.4 5 Compounding this problem are nutritional deficiencies, a frequent complication and comorbidity of IBD. Overt malnutrition (ie, undernutrition and overnutrition) like IBD is characterised by chronic inflammation, mucosal damage, intestinal barrier dysfunction, gut microbiome dysbiosis, altered immune response and malabsorption.6 In countries where childhood undernutrition is endemic, this presents an additional challenge in distinguishing malnutrition secondary to IBD. Additionally, nutritional deficiencies can worsen IBD pathophysiology and impede therapeutic response complicating disease management.6 This may lead to further misdiagnosis and underreporting of IBD’s prevalence in sub-Saharan Africa. Therefore, there is a crucial need to understand these challenges and underlying malnutrition in these settings. Moreover, reconciling malnutrition-driven pathologies may reveal unique subtypes of IBD, requiring a different approach to diagnosis and management.
- 16 November 2023
- Published by Springer Nature in Nature Microbiology
- Vol. 8 (12) , 2392-2405
Multiple micronutrient deficiencies in early life cause multi-kingdom alterations in the gut microbiome and intrinsic antibiotic resistance genes in mice
Globally, ~340 million children suffer from multiple micronutrient deficiencies, accompanied by high pathogenic burden and death due to multidrug-resistant bacteria. The microbiome is a reservoir of antimicrobial resistance (AMR), but the implications of undernutrition on the resistome is unclear. Here we used a postnatal mouse model that is deficient in multiple micronutrients (that is, zinc, folate, iron, vitamin A and vitamin B12 deficient) and shotgun metagenomic sequencing of faecal samples to characterize gut microbiome structure and functional potential, and the resistome. Enterobacteriaceae were enriched in micronutrient-deficient mice compared with mice fed an isocaloric experimental control diet. The mycobiome and virome were also altered with multiple micronutrient deficiencies including increased fungal pathogens such as Candida dubliniensis and bacteriophages. Despite being antibiotic naïve, micronutrient deficiency was associated with increased enrichment of genes and gene networks encoded by pathogenic bacteria that are directly or indirectly associated with intrinsic antibiotic resistance. Bacterial oxidative stress was associated with intrinsic antibiotic resistance in these mice. This analysis reveals multi-kingdom alterations in the gut microbiome as a result of co-occurring multiple micronutrient deficiencies and the implications for antibiotic resistance.
- 16 November 2023
- Published by Springer Nature in Nature Microbiology
- Vol. 8 (12) , 2392-2405
Multiple micronutrient deficiencies in early life cause multi-kingdom alterations in the gut microbiome and intrinsic antibiotic resistance genes in mice
Globally, ~340 million children suffer from multiple micronutrient deficiencies, accompanied by high pathogenic burden and death due to multidrug-resistant bacteria. The microbiome is a reservoir of antimicrobial resistance (AMR), but the implications of undernutrition on the resistome is unclear. Here we used a postnatal mouse model that is deficient in multiple micronutrients (that is, zinc, folate, iron, vitamin A and vitamin B12 deficient) and shotgun metagenomic sequencing of faecal samples to characterize gut microbiome structure and functional potential, and the resistome. Enterobacteriaceae were enriched in micronutrient-deficient mice compared with mice fed an isocaloric experimental control diet. The mycobiome and virome were also altered with multiple micronutrient deficiencies including increased fungal pathogens such as Candida dubliniensis and bacteriophages. Despite being antibiotic naïve, micronutrient deficiency was associated with increased enrichment of genes and gene networks encoded by pathogenic bacteria that are directly or indirectly associated with intrinsic antibiotic resistance. Bacterial oxidative stress was associated with intrinsic antibiotic resistance in these mice. This analysis reveals multi-kingdom alterations in the gut microbiome as a result of co-occurring multiple micronutrient deficiencies and the implications for antibiotic resistance.
- Open Access
- 27 September 2022
- Published by Springer Nature in Research Square
Early-life exposure to multiple micronutrient deficiencies induces clinically-relevant antibiotic resistance in a pre-clinical murine model
Globally, ~340 million children (<5 years) suffer from multiple micronutrient deficiencies, accompanied by high pathogenic burden and death due to multi-drug resistant bacteria. The role of early-life micronutrient deficiencies in mitigating antibiotic resistance within the host microbiota remains unexplored. We developed a postnatal preclinical murine model deficient in multiple micronutrients: zinc, folate, iron, vitamin A, and vitamin B12. Fecal metagenomic sequencing after dietary exposure revealed enrichment in the relative abundance of pathobionts and antibiotic resistance mechanisms including efflux pumps, target drug site alteration, antibiotic degrading enzymes, permeability, and acquisition of antibiotic resistance genes (ARGs). Despite being antibiotic naïve, we observed increased abundance of genes encoding resistance to several antibiotic classes: tetracycline, vancomycin, methicillin, fosfomycin, aminoglycosides and glycopeptides. Moreover, in vitro antibiotic susceptibility testing revealed clinically-relevant resistance to multiple antibiotic classes, namely vancomycin, methicillin, amoxicillin and erythromycin in mice fed the low-micronutrient diet. These novel findings present an unappreciated and profound role of cooccurring multiple micronutrient deficiencies in contributing to the global burden of antibiotic resistance, with significant clinical implications for undernourished children living in low-to-mid income countries.
- 27 September 2022
- Published by Springer Nature in Research Square
Open AccessEarly-life exposure to multiple micronutrient deficiencies induces clinically-relevant antibiotic resistance in a pre-clinical murine model
Globally, ~340 million children (<5 years) suffer from multiple micronutrient deficiencies, accompanied by high pathogenic burden and death due to multi-drug resistant bacteria. The role of early-life micronutrient deficiencies in mitigating antibiotic resistance within the host microbiota remains unexplored. We developed a postnatal preclinical murine model deficient in multiple micronutrients: zinc, folate, iron, vitamin A, and vitamin B12. Fecal metagenomic sequencing after dietary exposure revealed enrichment in the relative abundance of pathobionts and antibiotic resistance mechanisms including efflux pumps, target drug site alteration, antibiotic degrading enzymes, permeability, and acquisition of antibiotic resistance genes (ARGs). Despite being antibiotic naïve, we observed increased abundance of genes encoding resistance to several antibiotic classes: tetracycline, vancomycin, methicillin, fosfomycin, aminoglycosides and glycopeptides. Moreover, in vitro antibiotic susceptibility testing revealed clinically-relevant resistance to multiple antibiotic classes, namely vancomycin, methicillin, amoxicillin and erythromycin in mice fed the low-micronutrient diet. These novel findings present an unappreciated and profound role of cooccurring multiple micronutrient deficiencies in contributing to the global burden of antibiotic resistance, with significant clinical implications for undernourished children living in low-to-mid income countries.
- Top Cited PapersOpen Access
- 3 March 2022
- Published by Elsevier in Gastroenterology
- Vol. 162 (7) , 1858-1875.e2
Nonalcoholic Fatty Liver Disease and the Gut-Liver Axis: Exploring an Undernutrition Perspective
- 3 March 2022
- Published by Elsevier in Gastroenterology
- Vol. 162 (7) , 1858-1875.e2
Top Cited PapersOpen AccessNonalcoholic Fatty Liver Disease and the Gut-Liver Axis: Exploring an Undernutrition Perspective
- 17 August 2021
- Published by Springer Nature in Nature
- Vol. 596 (7872) , 343
Use photos of Black doctors and patients to heal not hurt
- 17 August 2021
- Published by Springer Nature in Nature
- Vol. 596 (7872) , 343
Use photos of Black doctors and patients to heal not hurt
- Open Access
- 28 January 2021
- Published by Springer Nature in BMC Medicine
- Vol. 19 (1) , 1-8
When a pandemic and an epidemic collide: COVID-19, gut microbiota, and the double burden of malnutrition
Background: It is estimated that the COVID-19 pandemic will drastically increase all forms of malnutrition. Of particular concern, yet understated, is the potential to increase the double burden of malnutrition (DBM) epidemic. This coexistence of undernutrition together with overweight and obesity, or diet-related non-communicable disease (NCD), within low- to middle-income countries (LMICs) is increasing rapidly. Although multiple factors contribute to the DBM, food insecurity (FI) and gut microbiota dysbiosis play a crucial role. Both under- and overnutrition have been shown to be a consequence of food insecurity. The gut microbiota has also been recently implicated in playing a role in under- and overnutrition, with altered community structure and function common to both. The pandemic has already caused significant shifts in food availability which has immediate effects on the gut microbiome. In this opinion paper, we discuss how COVID-19 may indirectly exacerbate the DBM through food insecurity and the gut microbiome. Main text: The World Food Programme (WFP) estimates that 265 million people in LMICs will experience acute hunger in 2020 due to the pandemic, nearly doubling the original projection of 135 million. Global border closures to food trade, loss of food production, and stark decline in household income will exacerbate starvation while simultaneously necessitating that families resort to calorie-dense, nutrient-poor foods, thereby increasing obesity. While food insecurity, which is the persistent lack of consistent access to adequate and nutrient-rich foods, will primarily drive nutrition behavior, the gut microbiome is perhaps a key biological mechanism. Numerous human and animal studies describe low diversity and an increase in inflammatory species as characteristic features of the undernourished and overnourished gut microbiota. Indeed, fecal transplant studies show that microbiota transfer from undernourished and overnourished humans to germ-free mice lacking a microbiome transfers the physical and metabolic phenotype, suggesting a causal role for the microbiota in under- and overnutrition. The observed microbiome dysbiosis within severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) coupled with the DBM presents a viscous cycle. Conclusion: Low- to mid-income countries will likely see an increase in the DBM epidemic. Providing access to nutritious foods and protecting individuals’ gut microbiome to “flatten the curve” of the DBM trajectory should be prioritized.
- 28 January 2021
- Published by Springer Nature in BMC Medicine
- Vol. 19 (1) , 1-8
Open AccessWhen a pandemic and an epidemic collide: COVID-19, gut microbiota, and the double burden of malnutrition
Background: It is estimated that the COVID-19 pandemic will drastically increase all forms of malnutrition. Of particular concern, yet understated, is the potential to increase the double burden of malnutrition (DBM) epidemic. This coexistence of undernutrition together with overweight and obesity, or diet-related non-communicable disease (NCD), within low- to middle-income countries (LMICs) is increasing rapidly. Although multiple factors contribute to the DBM, food insecurity (FI) and gut microbiota dysbiosis play a crucial role. Both under- and overnutrition have been shown to be a consequence of food insecurity. The gut microbiota has also been recently implicated in playing a role in under- and overnutrition, with altered community structure and function common to both. The pandemic has already caused significant shifts in food availability which has immediate effects on the gut microbiome. In this opinion paper, we discuss how COVID-19 may indirectly exacerbate the DBM through food insecurity and the gut microbiome. Main text: The World Food Programme (WFP) estimates that 265 million people in LMICs will experience acute hunger in 2020 due to the pandemic, nearly doubling the original projection of 135 million. Global border closures to food trade, loss of food production, and stark decline in household income will exacerbate starvation while simultaneously necessitating that families resort to calorie-dense, nutrient-poor foods, thereby increasing obesity. While food insecurity, which is the persistent lack of consistent access to adequate and nutrient-rich foods, will primarily drive nutrition behavior, the gut microbiome is perhaps a key biological mechanism. Numerous human and animal studies describe low diversity and an increase in inflammatory species as characteristic features of the undernourished and overnourished gut microbiota. Indeed, fecal transplant studies show that microbiota transfer from undernourished and overnourished humans to germ-free mice lacking a microbiome transfers the physical and metabolic phenotype, suggesting a causal role for the microbiota in under- and overnutrition. The observed microbiome dysbiosis within severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) coupled with the DBM presents a viscous cycle. Conclusion: Low- to mid-income countries will likely see an increase in the DBM epidemic. Providing access to nutritious foods and protecting individuals’ gut microbiome to “flatten the curve” of the DBM trajectory should be prioritized.
- Open Access
- 28 June 2019
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 21 (6) , e12580
Comparison of Nutrigenomics Technology Interface Tools for Consumers and Health Professionals: A Sequential Explanatory Mixed Methods Investigation
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet
- 28 June 2019
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 21 (6) , e12580
Open AccessComparison of Nutrigenomics Technology Interface Tools for Consumers and Health Professionals: A Sequential Explanatory Mixed Methods Investigation
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet
- Open Access
- 11 June 2018
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 7 (6) , e115
Comparison of Nutrigenomics Technology Interface Tools for Consumers and Health Professionals: Protocol for a Mixed-Methods Study
Background: Although nutrition interventions are a widely accepted resource for the prevention of long-term health conditions, current approaches have not adequately reduced chronic disease morbidity. Nutrigenomics has great potential; however, it is complicated to implement. There is a need for products based on nutrition-related gene test results that are easily understood, accessible, and used. Objective: The primary objective of this study was to compare a nonpractitioner-assisted direct-to-consumer self-driven approach to nutrigenomics versus an integrated and personalized practitioner-led method. Methods: This 4-month study used a mixed-methods design that included (1) a phase 1 randomized controlled trial that examined the effectiveness of a multifaceted, nutrition-based gene test (components assessed included major nutrients, food tolerances, food taste and preferences, and micronutrients) in changing health behaviors, followed by (2) a qualitative investigation that explored participants' experiences. The study recruited 55 healthy males and females (aged 35-55 years) randomized as a 2: 1 ratio where 36 received the intervention (gene test results plus integrated and personalized nutrition report) and 19 were assigned to the control group (gene test results report emailed). The primary outcomes of interest measures included changes in diet (nutrients, healthy eating index), changes in measures on General Self-efficacy and Health-Related Quality of Life scales, and anthropometrics (body mass index, waist-to-hip ratio) measured at baseline, post intervention (3 and 6 weeks), and the final visit (week 9 post intervention). Results: Of the 478 individuals who expressed interest, 180 were invited (37.7%, 180/478) and completed the eligibility screening questionnaire; 73 of the 180 invited individuals (40.5%) were deemed eligible. Of the 73 individuals who were deemed to be eligible, 58 completed the baseline health questionnaire and food records (79%). Of these 58 individuals, 3 were excluded either because they did not complete all required data collection forms or were later found to be ineligible. The final sample (n=55) was mostly female (75%), married (85%), and those who had completed postsecondary education (62%). Conclusions: This study will leverage quantitative and qualitative findings, which will guide the development of nutrigenomics-based products in electronic formats that are user-friendly for consumers and health professionals. Although the quantitative data have not been analyzed yet, the overwhelming interest in the study and the extremely high retention rate show that there is a great degree of interest in this field. Given this interest and the fact that nutrigenomics is an evolving science, a need for continued research exists to further the understanding of the role of genetic variation and its role and applications in nutrition practice.
- 11 June 2018
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 7 (6) , e115
Open AccessComparison of Nutrigenomics Technology Interface Tools for Consumers and Health Professionals: Protocol for a Mixed-Methods Study
Background: Although nutrition interventions are a widely accepted resource for the prevention of long-term health conditions, current approaches have not adequately reduced chronic disease morbidity. Nutrigenomics has great potential; however, it is complicated to implement. There is a need for products based on nutrition-related gene test results that are easily understood, accessible, and used. Objective: The primary objective of this study was to compare a nonpractitioner-assisted direct-to-consumer self-driven approach to nutrigenomics versus an integrated and personalized practitioner-led method. Methods: This 4-month study used a mixed-methods design that included (1) a phase 1 randomized controlled trial that examined the effectiveness of a multifaceted, nutrition-based gene test (components assessed included major nutrients, food tolerances, food taste and preferences, and micronutrients) in changing health behaviors, followed by (2) a qualitative investigation that explored participants' experiences. The study recruited 55 healthy males and females (aged 35-55 years) randomized as a 2: 1 ratio where 36 received the intervention (gene test results plus integrated and personalized nutrition report) and 19 were assigned to the control group (gene test results report emailed). The primary outcomes of interest measures included changes in diet (nutrients, healthy eating index), changes in measures on General Self-efficacy and Health-Related Quality of Life scales, and anthropometrics (body mass index, waist-to-hip ratio) measured at baseline, post intervention (3 and 6 weeks), and the final visit (week 9 post intervention). Results: Of the 478 individuals who expressed interest, 180 were invited (37.7%, 180/478) and completed the eligibility screening questionnaire; 73 of the 180 invited individuals (40.5%) were deemed eligible. Of the 73 individuals who were deemed to be eligible, 58 completed the baseline health questionnaire and food records (79%). Of these 58 individuals, 3 were excluded either because they did not complete all required data collection forms or were later found to be ineligible. The final sample (n=55) was mostly female (75%), married (85%), and those who had completed postsecondary education (62%). Conclusions: This study will leverage quantitative and qualitative findings, which will guide the development of nutrigenomics-based products in electronic formats that are user-friendly for consumers and health professionals. Although the quantitative data have not been analyzed yet, the overwhelming interest in the study and the extremely high retention rate show that there is a great degree of interest in this field. Given this interest and the fact that nutrigenomics is an evolving science, a need for continued research exists to further the understanding of the role of genetic variation and its role and applications in nutrition practice.
- Open Access
- 15 January 2018
- Published by JMIR Publications Inc. in JMIR Preprints
Comparison of Nutrigenomics Technology Interface Tools for Consumers and Health Professionals: Protocol for a Mixed-Methods Study (Preprint)
BACKGROUND Although nutrition interventions are a widely accepted resource for the prevention of long-term health conditions, current approaches have not adequately reduced chronic disease morbidity. Nutrigenomics has great potential; however, it is complicated to implement. There is a need for products based on nutrition-related gene test results that are easily understood, accessible, and used. OBJECTIVE The primary objective of this study was to compare a nonpractitioner-assisted direct-to-consumer self-driven approach to nutrigenomics versus an integrated and personalized practitioner-led method. METHODS This 4-month study used a mixed-methods design that included (1) a phase 1 randomized controlled trial that examined the effectiveness of a multifaceted, nutrition-based gene test (components assessed included major nutrients, food tolerances, food taste and preferences, and micronutrients) in changing health behaviors, followed by (2) a qualitative investigation that explored participants’ experiences. The study recruited 55 healthy males and females (aged 35-55 years) randomized as a 2:1 ratio where 36 received the intervention (gene test results plus integrated and personalized nutrition report) and 19 were assigned to the control group (gene test results report emailed). The primary outcomes of interest measures included changes in diet (nutrients, healthy eating index), changes in measures on General Self-efficacy and Health-Related Quality of Life scales, and anthropometrics (body mass index, waist-to-hip ratio) measured at baseline, post intervention (3 and 6 weeks), and the final visit (week 9 post intervention). RESULTS Of the 478 individuals who expressed interest, 180 were invited (37.7%, 180/478) and completed the eligibility screening questionnaire; 73 of the 180 invited individuals (40.5%) were deemed eligible. Of the 73 individuals who were deemed to be eligible, 58 completed the baseline health questionnaire and food records (79%). Of these 58 individuals, 3 were excluded either because they did not complete all required data collection forms or were later found to be ineligible. The final sample (n=55) was mostly female (75%), married (85%), and those who had completed postsecondary education (62%). CONCLUSIONS This study will leverage quantitative and qualitative findings, which will guide the development of nutrigenomics-based products in electronic formats that are user-friendly for consumers and health professionals. Although the quantitative data have not been analyzed yet, the overwhelming interest in the study and the extremely high retention rate show that there is a great degree of interest in this field. Given this interest and the fact that nutrigenomics is an evolving science, a need for continued research exists to further the understanding of the role of genetic variation and its role and applications in nutrition practice. CLINICALTRIAL Clinicaltrials.gov NCT03310814; http://clinicaltrials.gov/ct2/show/NCT03310814 (Archived by WebCite at http://www.webcitation.org/6yGnU5deB) REGISTERED REPORT IDENTIFIER RR1-10.2196/9846
- 15 January 2018
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessComparison of Nutrigenomics Technology Interface Tools for Consumers and Health Professionals: Protocol for a Mixed-Methods Study (Preprint)
BACKGROUND Although nutrition interventions are a widely accepted resource for the prevention of long-term health conditions, current approaches have not adequately reduced chronic disease morbidity. Nutrigenomics has great potential; however, it is complicated to implement. There is a need for products based on nutrition-related gene test results that are easily understood, accessible, and used. OBJECTIVE The primary objective of this study was to compare a nonpractitioner-assisted direct-to-consumer self-driven approach to nutrigenomics versus an integrated and personalized practitioner-led method. METHODS This 4-month study used a mixed-methods design that included (1) a phase 1 randomized controlled trial that examined the effectiveness of a multifaceted, nutrition-based gene test (components assessed included major nutrients, food tolerances, food taste and preferences, and micronutrients) in changing health behaviors, followed by (2) a qualitative investigation that explored participants’ experiences. The study recruited 55 healthy males and females (aged 35-55 years) randomized as a 2:1 ratio where 36 received the intervention (gene test results plus integrated and personalized nutrition report) and 19 were assigned to the control group (gene test results report emailed). The primary outcomes of interest measures included changes in diet (nutrients, healthy eating index), changes in measures on General Self-efficacy and Health-Related Quality of Life scales, and anthropometrics (body mass index, waist-to-hip ratio) measured at baseline, post intervention (3 and 6 weeks), and the final visit (week 9 post intervention). RESULTS Of the 478 individuals who expressed interest, 180 were invited (37.7%, 180/478) and completed the eligibility screening questionnaire; 73 of the 180 invited individuals (40.5%) were deemed eligible. Of the 73 individuals who were deemed to be eligible, 58 completed the baseline health questionnaire and food records (79%). Of these 58 individuals, 3 were excluded either because they did not complete all required data collection forms or were later found to be ineligible. The final sample (n=55) was mostly female (75%), married (85%), and those who had completed postsecondary education (62%). CONCLUSIONS This study will leverage quantitative and qualitative findings, which will guide the development of nutrigenomics-based products in electronic formats that are user-friendly for consumers and health professionals. Although the quantitative data have not been analyzed yet, the overwhelming interest in the study and the extremely high retention rate show that there is a great degree of interest in this field. Given this interest and the fact that nutrigenomics is an evolving science, a need for continued research exists to further the understanding of the role of genetic variation and its role and applications in nutrition practice. CLINICALTRIAL Clinicaltrials.gov NCT03310814; http://clinicaltrials.gov/ct2/show/NCT03310814 (Archived by WebCite at http://www.webcitation.org/6yGnU5deB) REGISTERED REPORT IDENTIFIER RR1-10.2196/9846